Anna leads the Strategy & Corporate Finance Practice for Switzerland and co-leads our separation and spin-off service line worldwide. She is a globally recognized merger management and carve-out adviser specializing in supporting boards and management teams in designing, planning, and executing complex, cross-border integrations, separations, and alliances.
Anna has over 20 years of M&A experience and has supported more than 150 M&A deals, ranging from $200 million to $50 billion. She works across industries with a focus on Life Sciences, Consumer and Chemicals. She regularly lectures on M&A topics at business schools across Europe and has authored numerous studies and is co-author of the Divestiture chapter of the Valuation Book.
In addition to her work in M&A, she is also passionate about diversity and has served on multiple boards, e.g. as chairwoman of Advance, to further diversity and inclusion.
Published work
“How CHROs can win hearts and minds in a buy-side carve-out,” McKinsey & Company, August 2025
“What CFOs need to get right in a buy-side carve-out,” McKinsey & Company, August 2025
“The cost of (un)doing business” McKinsey & Company, July 2025
“How buyers can successfully navigate integrating a carve-out” McKinsey & Company, July 2025
“CEOs in M&A: Five actions only the chief executive can take” McKinsey & Company, February 2025
“When separating businesses, people are the key to unleashing value,” McKinsey & Company, January 2025
“What it takes to make separations a competitive difference-maker,” McKinsey & Company, December 2024
“Active portfolio management: Five practical insights for value creation,” McKinsey & Company, November 2024
“It Does Take a Village,” Advance, June 2024
“The unseen code: Unlock Switzerland’s female tech potential,” McKinsey Quarterly, March 2024
“The equity story you need for the long-term investors you want,” McKinsey Quarterly, February 2024
“Climbing Higher,” Advance, April 2023
“The power of goodbye: How separations can unleash value,” McKinsey Quarterly, February 2023
“Five ways biopharma companies can navigate the deal landscape,” McKinsey & Company, February 2023
“Kids or career? Switzerland’s unnecessary dilemma,” Advance Whitepaper, February 2022
PAST EXPERIENCE
Deloitte
Global Managing Partner Integrations and Separations
Gyrus Capital
Operating Advisory Partner
Advance
President of the Board
EDUCATION
University of Gothenburg
MS and BA, business administration and economics